Target
Bromodomain-containing protein 3 [326-398]
Ligand
BDBM186321
Substrate
n/a
Meas. Tech.
FP Competitive Binding Assay (No.350)
Temperature
298.15±n/a K
Ki
1279±1069 nM
Comments
extracted
Citation
 Wang, SRan, XZhao, YYang, CLiu, LBai, LMcEachern, DStuckey, JMeagher, JLSun, DLi, XZhou, BKaratas, HLuo, RChinnaiyan, AAsangani, IA BET bromodomain inhibitors and therapeutic methods using the same US Patent  US9675697 Publication Date 6/13/2017 
Target
Name:
Bromodomain-containing protein 3 [326-398]
Synonyms:
BRD3 | BRD3_HUMAN | Bromodomain-containing protein 3 (BRD3)(BD2) | Bromodomain-containing protein 3 Bromo 2 domain(BRD3 BD2) | KIAA0043 | RING3L
Type:
n/a
Mol. Mass.:
8553.07
Organism:
Homo sapiens (Human)
Description:
BD2 (326-398 aa) of Q15059
Residue:
73
Sequence:
KHAAYAWPFYKPVDAEALELHDYHDIIKHPMDLSTVKRKMDGREYPDAQGFAADVRLMFSNCYKYNPPDHEVV
  
Inhibitor
Name:
BDBM186321
Synonyms:
US9675697, RX-38
Type:
n/a
Emp. Form.:
C18H16ClN3O2
Mol. Mass.:
341.792
SMILES:
CCc1onc(C)c1-c1cc2[nH]c3ccnc(Cl)c3c2cc1OC |(8.51,.94,;7.05,.46,;6.79,-.79,;7.86,-1.97,;7.06,-3.35,;5.51,-3.02,;4.56,-3.87,;5.36,-1.45,;3.99,-.65,;2.64,-1.4,;1.32,-.65,;.02,-1.4,;-1.28,-.65,;-2.62,-1.4,;-3.9,-.65,;-3.9,.87,;-2.62,1.63,;-2.64,3.17,;-1.28,.87,;1.32,.87,;2.64,1.63,;3.99,.87,;5.36,1.67,;5.36,2.94,)|
Structure:
Search PDB for entries with ligand similarity: